Episode 20 – EAACI 2024 reflections
An episode of the All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit podcast, hosted by ACARE, the Global Allergy and Asthma Excellence Network for Angioedema, titled "Episode 20 – EAACI 2024 reflections" was published on June 18, 2024 and runs 21 minutes.
June 18, 2024 ·21m · All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit
Summary
Dr Thomas Buttgereit asks Dr Clemens Schöffl about EAACI Congress 2024 highlights, which include early data on outcomes of CRISPR-based gene editing of KLKB1 in people with HAE. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: EAACI Congress 2024 – Breakthroughs in management of hereditary angioedema; CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema; Clinical experience with berotralstat in patients with hereditary angioedema with normal C1-esterase inhibitor: A commented case series.
Episode Description
Similar Episodes
Apr 17, 2026 ·34m
Apr 16, 2026 ·26m
Apr 15, 2026 ·37m
Apr 14, 2026 ·40m
Apr 13, 2026 ·23m
Apr 10, 2026 ·34m